Helping you deliver lasting outcomes for your patients.
Our mission is to give clinicians access to proven, off-the-shelf solutions that change the trajectory of equine care.
Meet our team
Dedicated to advancing equine medicine through science and innovation
Our team combines expertise in veterinary medicine, biotechnology, and clinical research to bring Bio-PLY™ from discovery to the horses who need it most.
Jessica Gilbertie MS DVM PhD
Founder
Michael Miller MS
CEO
Thomas Schaer VMD
Preclinical & Translational Advisor
Lauren Schnable DVM PhD DAVS DACSMR
Equine Industry Liaison
Proven Impact
Delivering real results for equine health
600k+
Horses affected by musculoskeletal injuries each year
“Current treatments only mask pain. Bio-PLY™ is finally addressing the root cause.”
Veterinary Research Partner
90%+
Of trial veterinarians reported improved patient mobility
“Bio-PLY™ gave my patients a chance at true recovery, not just temporary relief.”
Equine Clinician
2024 → 2026
Clinical trials launched toward FDA approval
“This is the future of equine orthobiologics, and I’m proud to be part of it.”
Trial Participant Vet
Bio-PLY™ is redefining equine care worldwide
Join us in transforming equine medicine with Bio-PLY™
With over 600,000 horses retiring or lost each year to musculoskeletal injuries, the market for effective orthobiologics is vast. Qentoros is advancing Bio-PLY™ toward FDA approval — creating a first-of-its-kind therapeutic with both clinical and commercial impact.
